Where we are with drugs for COVID-19?

Cardiovascular researcher Professor Martin Landray, from Oxford University, shares his thoughts
Medicom Staff writer
Professor Martin Landray
Professor Martin Landray.

AusDoc brings you the latest news from the European Society of Cardiology Congress 2020.

A single drug is unlikely to provide a ‘big win’ for treatment of COVID-19 — instead we are going to need to make the most of moderate benefits, according to a leading researcher and big data expert.